Pre-Surgical Qigong Therapy for Women With Breast Cancer
Completed
Conditions studied: Breast Cancer
In brief
The use of complementary and alternative medicine (CAM) in the United States has increased dramatically in the past 10 years. Nowhere is this trend more apparent than when one examines CAM use by patients diagnosed with cancer. As with the general population, patients with cancer typically use CAM-based modalities alongside their conventional cancer treatments. Patients are often seeking a holistic approach to managing and preventing disease. Although most patients will combine alternative approaches with conventional medicine, some patients do in fact decline curative conventional treatments in favor of more non-toxic alternative approaches. One such approach that patients combine with conventional medicine or use in place of conventional medicine is qigong. Qigong is a bioenergy therapy with a long history of therapeutic use for many diseases, including cancer. Preliminary experiments and a review of the literature show that qigong might improve the outcome for cancer patients. However, none of this research has been confirmed in the peer-reviewed Western scientific literature. Although it is unlikely that EQT will result in significant decreases in tumor size, patients are using qigong either as a complementary approach, and sometimes even in place of conventional medicine, it is, therefore, important for us to determine whether there is any merit to this treatment modality. The goal of this pilot trial is to examine one form of medical qigong (external qi therapy (EQT)) to determine feasibility. In an exploratory nature we will also examine any changes in tumor size in women with breast cancer who are awaiting surgery.
Key facts
- Study ID
- NCT00495209
- Run by
- M.D. Anderson Cancer Center
- People needed
- 7
- Starts
- 2006-07-26
- Expected to finish
- 2018-03-07
- Last updated by the study team
- 2018-08-15
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Histologically confirmed and intact invasive ductal carcinoma
- Women with a single measurable mass less than or equal to 3 cm
- Women who are awaiting the surgical removal of breast cancer
- Surgery is scheduled at least 2 weeks from the time of recruitment
- Willing to come to MDACC or Fudan University Cancer Hospital (FUCH) for 5 consecutive days to receive the EQT
- 18 years of age or older because the assessment tools are not validated for use in minors.
You may not qualify if…
- Women with lobular carcinoma
- Prior or planned neoadjuvant treatment with chemotherapy or radiotherapy
- Evidence of metastatic disease
Where it is running
- UT MD Anderson Cancer Center — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.